How to raise the profile of radiation oncology, one ASTRO member at a time
More than 100 years after it debuted as a mainstream cancer treatment, radiation oncology is still somewhat of an unknown specialty to the general public. Even over the course of my own career (14 years), I have been consistently surprised at the high number of misconceptions and general lack of awareness about radiation therapy and its benefits and effectiveness in treating cancer.
Merit-based Incentive Payment System Fourth Quarter UpdatesIt’s difficult to keep track of all the administrative deadlines within a radiation oncology practice. This is especially true for those practices reporting to Medicare’s Merit-based Incentive Payment System (MIPS). As we near the end of the second year of the MIPS program, there are several requirements to consider to check off the end-of-year “to do” list.Radiation Oncology Reimbursement Reminders (RORR), Fall 2018
In addition to providing resources to assist practices in submitting accurate claims for reimbursement, ASTRO is actively working with payers on coverage and payment issues. Recently, we received questions regarding reimbursement for radium-223 dichloride (Xofigo) and CMS’ Targeted Probe and Educate program.